bioMerieux' profits up 18% thanks to international sales
This article was originally published in Clinica
Executive Summary
Profits at French diagnostics company bioMerieux rose 18% in 1995 compared with the year before to Fr 139 million ($27.8 million). Sales volume increased 6% over the year, but weakness in the US dollar and several European currencies meant revenues rose just 2.1% to Fr 2,461 million in fiscal 1995 in what president Alain Merieux termed a difficult economic environment.